Current Report Filing (8-k)
September 08 2020 - 4:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): September 2, 2020
BIOSOLAR, INC.
(Exact name of registrant as specified in
its charter)
Nevada
|
|
000-54819
|
|
20-4754291
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer
|
of incorporation)
|
|
|
|
Identification No.)
|
27936 Lost Canyon Road, Suite 202,
Santa Clarita, CA 91387
(Address of principal executive offices
and Zip Code)
Registrant’s telephone number, including
area code: (661) 251-0001
Copies to:
Gregory Sichenzia, Esq.
Sichenzia Ross Ference LLP
1185 Avenue of the Americas, 37th Floor
New York, New York 10036
Phone: (212) 930-9700
Fax: (212) 930-9725
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered
pursuant to Section 12(b) of the Act: None.
Indicate by check
mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).
Emerging growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.02 Unregistered Sales of Equity
Securities.
As previously reported, Biosolar, Inc.
(the “Company”) entered into securities purchase agreements pursuant to which it issued convertible notes to various
accredited investors, which notes are convertible into shares of the Company’s common stock on the terms and subject to the
conditions set forth in the various securities purchase agreements and associated notes. Through the date of this report, certain
accredited investors converted an aggregate of approximately $80,719.59 in principal and interest resulting in the issuance of
an aggregate of 24,613,172 shares of common stock.
The securities above were offered and
sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended,
since, among other things, the transactions did not involve a public offering of the securities.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
BIOSOLAR, INC.
|
|
|
Date: September 8, 2020
|
/s/ David Lee
|
|
David Lee
|
|
Chief Executive Officer
|
2